CNBX Pharmaceuticals files SEC 10-K annual report for key information
CNBX Pharmaceuticals Inc., a company specializing in pharmaceutical preparations, recently filed its Form 10-K annual report for August 2024. The filing, accessible at the Securities and Exchange Commission’s website, provides valuable insight into the company’s financial performance and operations during the specified period.
Attachments:
1. Form 10-K for August 2024
2. Certification Document 1
3. Certification Document 2
The filing includes various certifications, graphics, and data files that offer a comprehensive view of CNBX Pharmaceuticals Inc.’s activities. The company’s mailing address is located at #3 Bethesda Metro Center, Suite 700, Bethesda, MD 20814, with a business phone number of 877-424-2429.
For more information about CNBX Pharmaceuticals Inc., you can visit their [website](#) here.
To access the complete Form 10-K filing, please click here.
